Corcept Therapeutics (CORT) Competitors $51.83 -2.96 (-5.40%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CORT vs. AXSM, GBT, RARX, HRMY, XNCR, RPRX, JAZZ, PRGO, SUPN, and PCRXShould you be buying Corcept Therapeutics stock or one of its competitors? The main competitors of Corcept Therapeutics include Axsome Therapeutics (AXSM), Global Blood Therapeutics (GBT), Ra Pharmaceuticals (RARX), Harmony Biosciences (HRMY), Xencor (XNCR), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Supernus Pharmaceuticals (SUPN), and Pacira BioSciences (PCRX). Corcept Therapeutics vs. Axsome Therapeutics Global Blood Therapeutics Ra Pharmaceuticals Harmony Biosciences Xencor Royalty Pharma Jazz Pharmaceuticals Perrigo Supernus Pharmaceuticals Pacira BioSciences Corcept Therapeutics (NASDAQ:CORT) and Axsome Therapeutics (NASDAQ:AXSM) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, community ranking, analyst recommendations and valuation. Is CORT or AXSM more profitable? Corcept Therapeutics has a net margin of 22.35% compared to Axsome Therapeutics' net margin of -91.87%. Corcept Therapeutics' return on equity of 24.54% beat Axsome Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Corcept Therapeutics22.35% 24.54% 20.24% Axsome Therapeutics -91.87%-158.36%-37.46% Does the MarketBeat Community believe in CORT or AXSM? Corcept Therapeutics received 94 more outperform votes than Axsome Therapeutics when rated by MarketBeat users. Likewise, 71.13% of users gave Corcept Therapeutics an outperform vote while only 69.11% of users gave Axsome Therapeutics an outperform vote. CompanyUnderperformOutperformCorcept TherapeuticsOutperform Votes53771.13% Underperform Votes21828.87% Axsome TherapeuticsOutperform Votes44369.11% Underperform Votes19830.89% Which has stronger valuation & earnings, CORT or AXSM? Corcept Therapeutics has higher revenue and earnings than Axsome Therapeutics. Axsome Therapeutics is trading at a lower price-to-earnings ratio than Corcept Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCorcept Therapeutics$482.38M11.26$106.14M$1.2641.14Axsome Therapeutics$270.60M16.69-$239.24M-$6.53-14.27 Do insiders & institutionals believe in CORT or AXSM? 93.6% of Corcept Therapeutics shares are held by institutional investors. Comparatively, 81.5% of Axsome Therapeutics shares are held by institutional investors. 20.5% of Corcept Therapeutics shares are held by insiders. Comparatively, 22.4% of Axsome Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts rate CORT or AXSM? Corcept Therapeutics presently has a consensus target price of $65.25, suggesting a potential upside of 25.89%. Axsome Therapeutics has a consensus target price of $124.93, suggesting a potential upside of 34.09%. Given Axsome Therapeutics' higher possible upside, analysts plainly believe Axsome Therapeutics is more favorable than Corcept Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Corcept Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Axsome Therapeutics 0 Sell rating(s) 0 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor CORT or AXSM? In the previous week, Axsome Therapeutics had 26 more articles in the media than Corcept Therapeutics. MarketBeat recorded 39 mentions for Axsome Therapeutics and 13 mentions for Corcept Therapeutics. Corcept Therapeutics' average media sentiment score of 1.19 beat Axsome Therapeutics' score of 0.55 indicating that Corcept Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Corcept Therapeutics 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Axsome Therapeutics 11 Very Positive mention(s) 4 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, CORT or AXSM? Corcept Therapeutics has a beta of 0.45, meaning that its stock price is 55% less volatile than the S&P 500. Comparatively, Axsome Therapeutics has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. SummaryCorcept Therapeutics beats Axsome Therapeutics on 11 of the 17 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CORT vs. The Competition Export to ExcelMetricCorcept TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.43B$6.52B$5.15B$8.74BDividend YieldN/A8.16%5.18%4.08%P/E Ratio41.144.8866.3713.55Price / Sales11.26376.691,276.8487.67Price / Cash54.1151.2039.7035.24Price / Book8.509.686.475.93Net Income$106.14M$154.43M$119.73M$225.73M7 Day Performance-13.04%-9.46%-5.13%-1.34%1 Month Performance9.88%-7.27%-2.71%1.15%1 Year Performance100.04%28.13%31.08%24.02% Corcept Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORTCorcept Therapeutics4.9414 of 5 stars$51.83-5.4%$65.25+25.9%+106.4%$5.43B$482.38M41.14300Insider SellingShort Interest ↓Positive NewsAXSMAxsome Therapeutics4.6834 of 5 stars$96.66-0.7%N/A+56.0%$4.68B$270.60M-14.80589Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGBTGlobal Blood TherapeuticsN/A$68.49flatN/A+0.0%$4.62B$194.75M-13.67457RARXRa PharmaceuticalsN/A$47.99flatN/A+0.0%$2.27B$3M-20.7772HRMYHarmony Biosciences4.8486 of 5 stars$32.97-0.1%N/A+28.5%$1.88B$582.02M15.63200Short Interest ↓XNCRXencor3.6086 of 5 stars$23.25-1.1%N/A+24.4%$1.63B$168.34M-7.27280Insider SellingRPRXRoyalty Pharma4.7879 of 5 stars$25.60+0.1%N/A-3.1%$15.19B$2.36B13.2680Positive NewsJAZZJazz Pharmaceuticals4.9305 of 5 stars$122.11-1.7%N/A-0.1%$7.38B$3.83B17.202,800Insider SellingPRGOPerrigo4.9632 of 5 stars$27.13+0.7%N/A-8.2%$3.70B$4.66B-23.199,140SUPNSupernus Pharmaceuticals2.6821 of 5 stars$35.54-1.8%N/A+27.6%$1.96B$607.52M33.22580Positive NewsPCRXPacira BioSciences3.9084 of 5 stars$16.45+0.5%N/A-40.6%$759.50M$674.98M-8.10720Analyst ForecastNews Coverage Related Companies and Tools Related Companies Axsome Therapeutics Competitors Global Blood Therapeutics Competitors Ra Pharmaceuticals Competitors Harmony Biosciences Competitors Xencor Competitors Royalty Pharma Competitors Jazz Pharmaceuticals Competitors Perrigo Competitors Supernus Pharmaceuticals Competitors Pacira BioSciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CORT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Corcept Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CORT Stock Alerts